About 100 reports

FIGURE ## TOP INVENTORS FOR COMPANION ANIMAL PHARMACEUTICALS PATENTS (2015–2020)

  • Pharmaceutical
  • World
  • Europe
  • North America
  • United States
  • APAC
  • Health Expenditure
  • Drug Approval

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain.Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors,...

  • Chronic Pain
  • Analgesic
  • Pharmaceutical
  • Biomaterial
  • Cell Therapy

Global Generic Drugs Market 2021-2025 The analyst has been monitoring the generic drugs market and it is poised to grow by $ 138.90 bn during 2021-2025, progressing at a CAGR of 6.33% during the forecast period. Our report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Generic Drug
  • World

TABLE ## DRUG PATENT EXPIRY, BY YEAR

  • Pharmaceutical Excipient
  • World
  • Europe
  • United States
  • North America
  • APAC
  • Health Expenditure
  • Pharmaceutical Production

Global MEK Inhibitors Market, Drug Sales & Clinical Trials insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global MEK Inhibitors Market Opportunity Assessment: > USD 3 Billion • Market & Drug Sales Insight 2020 Till 2026 • Approved Drug In Market: 4 Drugs •...

  • Clinical Trial
  • Targeted Therapy
  • World
  • Drug Approval

The Japan Pharmaceutical market studied was anticipated to show a slow growth with a CAGR of 1.06%. In Japan, the pharmaceutical industry has experienced modest growth patterns in recent years. Strong regulation and pricing systems, along with frequent price cuts, both made it almost impossible for pharmaceutical drug manufacturers to launch...

  • Pharmaceutical
  • Japan
  • Health Expenditure
  • Smoking Prevalence

"US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026" Report Highlights: • US HIV Infection Drugs Market & Clinical Trial Insight • Comprehensive Insight On Approved HIV Infection Drugs Price & Dosage Analysis For US Market • HIV Infection Drugs Patent Timeline • Dosage, Formulation, Patent,...

  • Pharmaceutical
  • HIV AIDS
  • United States
  • Drug Approval

"US Diabetes Drug Market, Dosage, Price, Sales Insight 2021 - 2026" Report Highlights: • US Diabetes Drugs Market & Clinical Trial Insight • Comprehensive Insight On Approved Diabetes Drugs Price & Dosage Analysis For US Market • Diabetes Drugs Patent Timeline • Dosage, Formulation, Patent, Pricing Insight...

  • Pharmaceutical
  • Diabetes
  • United States
  • Drug Approval

Avitaminosis (Hypovitaminosis) Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Avitaminosis (Hypovitaminosis) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Avitaminosis (Hypovitaminosis) Clinical trials scenario. This report provides...

  • Clinical Trial
  • World

Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global PDGFR Inhibitors Market Opportunity Assessment: > USD 4 Billion • Market & Drug Sales Insight 2020 Till 2026 •...

  • Pharmaceutical
  • Drug Development
  • World
  • Drug Approval
  • Health Expenditure

Global TRK Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global TRK Inhibitors Market Opportunity Assessment: > USD 2 Billion • Market & Drug Sales Insight 2020 Till 2026 • Approved Drug In Market: 2 Drugs •...

  • Pharmaceutical
  • Cancer
  • Drug Development
  • Clinical Trial
  • World
  • Drug Approval
  • Out Of Pocket Expenditure

Executive Summary The global generic injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the expiration of branded drug patents, rising approvals for generic injectable...

  • Pharmaceutical
  • Healthcare
  • Diabetes
  • World
  • Diabetes Prevalence
  • Health Expenditure

United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the...

  • Generic Drug
  • United States
  • Generics Use
  • Health Expenditure

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global BCMA Targeted Drugs Market Opportunity Assessment: > USD 4 Billion • Market and Drug Sales Insight 2020 Till 2026 • Approved...

  • Immunotherapy
  • Cancer
  • Monoclonal Antibody
  • World
  • Drug Approval

"US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026" Report highlights: • US Cancer Biosimilar Market Opportunity: > US$ 15 Billion By 2026 • Currently 29 Cancer Biosimilar Approved In US Market • Pricing & Dosage Insight On More Than 10 Cancer Biosimilar Commercially Available...

  • Biosimilar
  • Therapy
  • United States
  • Mortality Rate
  • Biosimilar Approvals

The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.73 billion in 2021; it is expected to grow at a CAGR of 10.5% from 2021 to 2028. Low R&D, marketing, and manufacturing costs and high demand for affordable drugs are driving the generic injectables market growth. However, the critical inspection...

  • Infectious Disease
  • World
  • APAC
  • Health Expenditure
  • Drug Approval

Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis - Drugs in Development, 2021, provides an overview of the Onychomycosis (Infectious Disease) pipeline landscape. Onychomycosis...

  • Antifungal
  • Pharmaceutical
  • Infectious Disease
  • Dermatological Condition
  • World
  • South Africa
  • Dropout Rate
  • Drug Approval

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D...

  • Research And Development
  • Generic Drug
  • Anti-Infective
  • Parenteral Nutrition
  • In-Store Retail
  • Chronic Disease
  • Pharmacy
  • Cardiology
  • World

Antiviral Combination Therapies Market – Scope of the Report This report on the global antiviral combination therapies market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030.The report provides the...

  • Antiviral
  • World

"US Alzheimer’s Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • US Alzheimer’s Disease Drug Market Opportunity: > US$ 5 Billion • US Accounts For More Than 40% of Global Alzheimer’s Disease Drug Market • US Alzheimer’s Disease Drug Clinical Trials: 200 Drugs in Pipeline •...

  • Dementia
  • United States
  • Drug Approval

The Pharmaceutical CDMO Market was valued at USD 183.62 billion in 2021. It is expected to reach USD 289.64 billion by 2027, registering a CAGR of 7.29% during the forecast period. Key Highlights As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business,...

  • Pharmaceutical
  • United States
  • World
  • Asia

INTRODUCTION Pharmaceutical manufacturing processes are complex, time consuming, as well as cost intensive. In fact, it is estimated that production inefficiencies and product recalls (owing to manufacturing errors) are responsible for annual losses amounting to around USD 50 billion. Given the ever-increasing demand for...

  • Pharmaceutical
  • APAC
  • Europe
  • North America

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Drug Development
  • World

TABLE ## PHARMACEUTICAL PATENT GRANTS, 2017 VS. 2019, BY COUNTRY

  • Pharmaceutical
  • Cell Therapy
  • Biotechnology
  • Research And Development
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Biologics Production
  • Health Expenditure

Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down. Description: Where...

  • Healthcare
  • World
  • Private Health Expenditure
  • Gross Domestic Product Per Capita

The global colorectal cancer market is expected to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027. Driving factors of the colorectal cancer are increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover,...

  • Colorectal Cancer
  • APAC
  • World
  • Europe
  • Colorectal Cancer Screening Coverage
  • Health Expenditure

Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing...

  • Generic Drug
  • World
  • Chronic Disease Prevalence
  • Diabetes Prevalence

Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of...

  • Drug Development
  • Pharmaceutical
  • World
  • Number Of Enterprises
  • Pharmaceutical R&D Expenditure

Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2020 Summary clinical trial report, “Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2020" provides an overview of Vitamin D Deficiency Disorders Clinical trials scenario.This report provides top line data relating...

  • Clinical Trial
  • World

Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment...

  • Oncology
  • World